Multiple mechanisms of age-dependent accumulation of amyloid beta protein in rat brain: Prevention by dietary supplementation with N-acetylcysteine, α-lipoic acid and α-tocopherol

Neurochemistry International

Volumn 95, Issue , 2016, Pages 92-99

  Sinha, Maitrayee ^a,b   Bir, Aritri ^a,c   Banerjee, Anindita ^a,c   Bhowmick, Pritha ^a   Chakrabarti, Sasanka ^a,c  

^a INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^b LINKÖPING UNIVERSITY   (Sweden)

^c Icare institute of Medical Sciences   (India)

Author keywords

Alzheimer's disease; Amyloid beta protein; Amyloid precursor protein; Antioxidant; Neprilysin; Secretase

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; MEMBRANE METALLOENDOPEPTIDASE; MESSENGER RNA; THIOCTIC ACID; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT;

AGED; AGING; ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; COGNITIVE DEFECT; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVITY; LONG TERM CARE; NONHUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; RAT; SPATIAL LEARNING; SPATIAL MEMORY; ANIMAL; ANTAGONISTS AND INHIBITORS; COMBINATION DRUG THERAPY; DIETARY SUPPLEMENT; DRUG EFFECTS; MAZE TEST; METABOLISM; PHYSIOLOGY; WISTAR RAT;

ACETYLCYSTEINE; AGING; ALPHA-TOCOPHEROL; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; DIETARY SUPPLEMENTS; DRUG THERAPY, COMBINATION; MAZE LEARNING; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; THIOCTIC ACID;

EID: 84949972776     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2015.10.003     Document Type: Article

References (65)

1. J. Apelt, M. Bigl, P. Wunderlich, and R. Schliebs Aging-related increase in oxidative stress correlates with developmental pattern of beta-secretase activity and beta-amyloid plaque formation intransgenic Tg2576 mice with Alzheimer-like pathology Int. J. Dev. Neurosci. 22 2004 475 484
2. +-ATPase activity and associated peroxidative damage in rat brain synaptosomes Biogerontol. 9 2008 421 428
3. M.B. Bagh, I.G. Thakurta, M. Biswas, P. Behera, and S. Chakrabarti Age-related oxidative decline of mitochondrial functions in rat brain is prevented by long term oral antioxidant supplementation Biogerontol. 12 2011 119 131
4. S. Bandyopadhyay, C. Cahill, A. Balleidier, C. Huang, D.K. Lahiri, X. Huang, and J.T. Rogers Novel 5' untranslated region directed blockers of iron-regulatory protein-1 dependent amyloid precursor protein translation: implications for Down syndrome and Alzheimer's disease PLoS One 8 2013 e65978
5. +-ATPase in rat brain crude synaptosomes Exp. Gerontol. 38 2003 705 710
6. L. Chami, and F. Checler BACE1 is at the crossroad of a toxic vicious cycle involving cellular stress and β-amyloid production in Alzheimer's disease Mol. Neurodegener. 7 2012 52 10.1186/1750-1326-7-52
7. C.H. Chen, W. Zhou, S. Liu, Y. Deng, F. Cai, M. Tone, and et al. Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease Int. J. Neuropsychopharmacol. 15 2012 77 90
8. H.H. Cho, C.M. Cahill, C.R. Vanderburg, C.R. Scherzer, B. Wang, X. Huang, and et al. Selective translational control of the Alzheimer amyloid precursor protein transcript by iron regulatory protein-1 J. Biol. Chem. 285 2010 31217 31232
9. R. Dosunmu, J. Wu, M.R. Basha, and N.H. Zawia Environmental and dietary risk factors in Alzheimer's disease Expert. Rev. Neurother. 7 2007 887 900
10. P.A. Dudchenko An overview of the tasks used to test working memory in rodents Neurosci. Biobehav. Rev. 28 2004 699 709
11. E.A. Eckman, and C.B. Eckman Abeta-degrading enzymes: modulators of Alzheimer's disease pathogenesis and targets for therapeutic intervention Biochem. Soc. Trans. 33 2005 1101 1105
12. R.M. Evans, S. Hui, A. Perkins, D.K. Lahiri, J. Poirier, and M.R. Farlow Cholesterol and APOE genotype interact to influence Alzheimer disease progression Neurology 62 2004 1869 1871
13. S. Fukami, K. Watanabe, N. Iwata, J. Haraoka, B. Lu, N.P. Gerard, and et al. Abeta-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with Abeta pathology Neurosci. Res. 43 2002 39 56
14. H. Fukumoto, B.S. Cheung, B.T. Hyman, and M.C. Irizarry Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease Arch. Neurol. 59 2002 1381 1389
15. H. Fukumoto, D.L. Rosene, M.B. Moss, S. Raju, B.T. Hyman, and M.C. Irizarry β Secretase activity increases with aging in human, monkey, and mouse brain Am. J. Pathol. 164 2004 719 725
16. D.R. Galasko, E. Peskind, C.M. Clark, J.F. Quinn, J.M. Ringman, G.A. Jicha, and et al. Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures Arch. Neurol. 69 2012 836 841
17. M. Genestra Oxyl radicals, redox-sensitive signalling cascades and antioxidants Cell. Signal. 19 2007 1807 1819
18. S. Ghosh, and M.K. Thakur PS2 protein expression is upregulated by sex steroids in the cerebral cortex of aging mice Neurochem. Int. 52 2008 363 367
19. B. Halliwell, and J.M.C. Gutteridge Free Radicals in Biology and Medicine fourth ed. 2007 Clarendon Press Oxford
20. M. Helenius, M. Hanninen, S.K. Lehtinen, and A. Salminen Aging-induced up-regulation of nuclear binding activities of oxidative stress responsive NF-κB transcription factor in mouse cardiac muscle J. Mol. Cell. Cardiol. 28 1996 487 498
21. L.B. Hersh, and D.W. Rodgers Neprilysin and amyloid beta peptide degradation Curr. Alzheimer Res. 5 2008 225 231
22. R.M. Holsinger, C.A. McLean, K. Beyreuther, C.L. Masters, and G. Evin Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease Ann. Neurol. 51 2002 783 786
23. B. Kaltschmidt, M. Uherek, B. Volk, P.A. Baeuerle, and C. Kaltschmidt Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease Proc. Natl. Acad. Sci. U. S. A. 94 1997 2642 2647
24. A. Kern, and C. Behl The unsolved relationship of brain aging and late onset Alzheimer disease Biochim. Biophys. Acta 1790 2009 1124 1132
25. R.P. Kesner, B.V. DiMattia, and K.A. Crutcher Evidence for neocortical involvement in reference memory Behav. Neural. Biol. 47 1987 40 53
26. R. Kimura, D. MacTavish, J. Yang, D. Westaway, and J.H. Jhamandas Beta amyloid-induced depression of hippocampal long-term potentiation is mediated through the amylin receptor J. Neurosci. 32 2012 17401 17406
27. P. Korhonen, M. Helenius, and A. Salminen Age-related changes in the regulation of transcription factor NF-kappa B in rat brain Neurosci. Lett. 225 1997 61 64
28. A. Kurz, and R. Perneczky Amyloid clearance as a treatment target against Alzheimer's disease J. Alzheimers Dis. 24 2011 61 73
29. W.C. Leon, M.A. Bruno, S. Allard, K. Nader, and A.C. Cuello Engagement of the PFC in consolidation and recall of recent spatial memory Learn. Mem. 17 2010 297 305
30. K. Leuner, S. Hauptmann, R. Abdel-Kader, I. Scherping, U. Keil, J.B. Strosznajder, and et al. Mitochondrial dysfunction: the first domino in brain aging and Alzheimer's disease? Antioxid. Redox. Signal. 9 2007 1659 1675
31. R. Li, K. Lindholm, L.B. Yang, X. Yue, M. Citron, R. Yan, and et al. Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients Proc. Natl. Acad. Sci. U. S. A. 101 2004 3632 3637
32. Y. Li, W. Zhou, Y. Tong, G. He, and W. Song Control of APP processing and Abeta generation level by BACE1 enzymatic activity and transcription FASEB J. 20 2006 285 292
33. M.T. Lin, and M.F. Beal Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases Nature 443 2006 787 795
34. A. Lloret, M.C. Badia, N.J. Mora, F.V. Pallardo, M.D. Alonso, and J. Vina Vitamin E paradox in Alzheimer's disease: it does not prevent loss of cognition and may even be detrimental J. Alzheimer Dis. 17 2009 143 149
35. X.G. Luo, J.Q. Ding, and S.D. Chen Microglia in the aging brain: relevance to neurodegeneration Mol. Neurodegener. 5 2010 10.1186/1750-1326-5-12
36. E. Mariani, M.C. Polidori, A. Cherubini, and P. Mecocci Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview J. Chromatogr. B. Anal. Technol. Biomed. Life. Sci. 827 2005 65 75
37. H.S. Marinho, C. Real, L. Cyrne, H. Soares, and F. Antunes Hydrogen peroxide sensing, signalling and regulation of transcription factors Redox. Biol. 2 2014 535 562
38. T. Montiel, R. Quiroz-Baez, L. Massieu, and C. Arias Role of oxidative stress on beta amyloid neurotoxicity elicited during impairment of energy metabolism in the hippocampus: protection by anti- oxidants Exp. Neurol. 200 2006 496 508
39. C. Oliveri, M.P. Ocaranza, X. Campos, S. Lavandero, and J.E. Jalil Angiotensin I-converting enzyme modulates neutral endopeptidase activity in the rat Hypertension 38 2001 650 654
40. M. Page, and R. Thorpe Protein blotting by electroblotting J.M. Walker, The Protein Protocols Handbook 2002 Humana Press Inc. New Jersey 317 319
41. M.W. Pfaffl A new mathematical model for relative quantification in real-time RT-PCR Nucleic Acids Res. 29 2001 2002 2007
42. V. Pop, E. Head, M.A. Hill, D. Gillen, N.C. Berchtold, B.A. Muggenburg, and et al. Synergistic effects of long-term antioxidant diet and behavioural enrichment on beta-amyloid load and non-amyloidogenic processing in aged canines J. Neurosci. 30 2010 9831 9839
43. C. Reitz, C. Brayne, and R. Mayeux Epidemiology of Alzheimer disease Nat. Rev. Neurol. 7 2011 137 152
44. K.M. Rodrigue, K.M. Kennedy, M.D. Devous Sr., J.R. Rieck, A.C. Hebrank, R. Diaz-Arrastia, and et al. β-Amyloid burden in healthy aging: regional distribution and cognitive consequences Neurology 78 2012 387 395
45. K.M. Rodrigue, K.M. Kennedy, and D.C. Park Beta-amyloid deposition and the aging brain Neuropsychol. Rev. 19 2009 436 450
46. J.T. Rogers, J.D. Randall, C.M. Cahill, P.S. Eder, X. Huang, H. Gunshin, and et al. An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript J. Biol. Chem. 277 2002 45518 45528
47. S. Seshadri, A. Beiser, J. Selhub, P.F. Jacques, I.H. Rosenberg, and R.B. D'Agostino Plasma homocysteine as a risk factor for dementia and Alzheimer's disease N. Engl. J. Med. 346 2002 476 483
48. E. Tarragon, L. Lopez, F. Ros-Bernal, J.E. Yuste, V. Ortiz-Cullera, E. Martin, and et al. The radial arm maze (ram) for the evaluation of working and reference memory deficits in the diurnal rodent Octodon degus A.J. Spink, F. Grieco, O.E. Krips, L.W.S. Loijens, L.P.J.J. Noldus, P.H. Zimmerman, Proceedings of Measuring Behavior 2012 2012 Noldus Information Technology bv. Wageningen 98 100
49. T.L. Tekirian, G.M. Cole, M.J. Russell, F. Yang, D.R. Wekstein, E. Patel, and et al. Carboxy terminal of beta-amyloid deposits in aged human, canine, and polar bear brains Neurobiol. Aging 17 1996 249 257
50. K. Terai, A. Matsuo, and P.L. McGeer Enhancement of immunoreactivity for NF-kappa B in the hippocampal formation and cerebral cortex of Alzheimer's disease Brain. Res. 735 1996 159 168
51. I.G. Thakurta, M. Chattopadhya, A. Ghosh, and S. Chakrabarti Dietary supplementation with N-acetylcysteine, α-tocopherol and α-lipoic acid reduces the extent of oxidative stress and proinflammatory state in aged rat brain Biogerontol. 13 2012 479 488
52. I.G. Thakurta, P. Banerjee, M.B. Bagh, A. Ghosh, A. Sahoo, S. Chattopadhyay, and et al. Combination of N-acetylcysteine, α-lipoic acid and α-tocopherol substantially prevents the brain synaptosomal alterations and memory and learning deficits of aged rats Exp. Gerontol. 50 2014 19 25
53. J. Theuns, and C. Van Broeckhoven Transcriptional regulation of Alzheimer's disease genes: implications for susceptibility Hum. Mol. Genet. 9 2000 2383 2394
54. J.S. Tilstra, C.L. Clauson, L.J. Niedernhofer, and P.D. Robbins NF-κB in aging and disease Aging Dis. 2 2011 449 465
55. S. Tucker, M. Ahl, H.H. Cho, S. Bandyopadhyay, G.D. Cuny, A.I. Bush, and et al. RNA therapeutics directed to the non coding regions of APP mRNA, in vivo anti-amyloid efficacy of paroxetine, erythromycin, and N-acetylcysteine Curr. Alzheimer Res. 3 2006 221 227
56. D.M. Walsh, I. Klyubin, J.V. Fadeeva, W.K. Cullen, R. Anwyl, M.S. Wolfe, and et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo Nature 416 2002 535 539
57. D.S. Wang, N. Iwata, E. Hama, T.C. Saido, and D.W. Dickson Oxidized neprilysin in aging and Alzheimer's disease brains Biochem. Biophys. Res. Commun. 310 2003 236 241
58. J. Winkler, S.T. Suhr, F.H. Gage, L.J. Thal, and L.J. Fisher Essential role of neocortical acetylcholine in spatial memory Nature 375 1995 484 487
59. T. Wyss-Coray, and J. Rogers Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature Cold. Spring. Harb. Perspect. Med. 2 2012 a006346
60. K. Yasojima, H. Akiyama, E.G. McGeer, and P.L. McGeer Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of beta-amyloid peptide Neurosci. Lett. 297 2001 97 100
61. Z. Ying, T. Kampfrath, Q. Sun, S. Parthasarathy, and S. Rajagopalan Evidence that α-lipoic acid inhibits NF-κB activation independent of its antioxidant function Inflamm. Res. 60 2011 219 225
62. T. Yoon, J. Okada, M.W. Jung, and J.J. Kim Prefrontal cortex and hippocampus subserve different components of working memory in rats Learn. Mem. 15 2008 97 105
63. A. Zaidi, and M.R. Michaelis Effects of reactive oxygen species on brain synaptic plasma membrane Ca(2+)-ATPase Free. Radic. Biol. Med. 27 1999 810 821
64. L. Zecca, M.B.H. Youdim, P. Riederer, J.R. Connor, and R.R. Crichton Iron, brain ageing and neurodegenerative disorders Nat. Rev. Neurosci. 5 2004 863 873
65. W.J. Zhang, and B. Frei Alpha-lipoic acid inhibits TNF-alpha-induced NF-kappaB activation and adhesion molecule expression in human aortic endothelial cells FASEB J. 15 2001 2423 2432